Leukotriene B4 receptor-1 mediates intermittent hypoxia-induced atherogenesis.
about
Obstructive sleep apnea and cognitive impairment: addressing the blood-brain barrierUpdate on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7Crystalline silica-induced leukotriene B4-dependent inflammation promotes lung tumour growthDeletion of metallothionein exacerbates intermittent hypoxia-induced oxidative and inflammatory injury in aorta.Cysteinyl leukotriene signaling aggravates myocardial hypoxia in experimental atherosclerotic heart diseaseLeukotriene B4 pathway activation and atherosclerosis in obstructive sleep apnea.NF-κB and hypoxia: a double-edged sword in atherosclerosisTranslational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea.Eicosanoids in metabolic syndrome.BLT1 signalling protects the liver against acetaminophen hepatotoxicity by preventing excessive accumulation of hepatic neutrophils.Chronic intermittent hypoxia induces atherosclerosis via activation of adipose angiopoietin-like 4.Expression of leukotriene B₄ receptor-1 on CD8⁺ T cells is required for their migration into tumors to elicit effective antitumor immunity.A pro-inflammatory role for nuclear factor kappa B in childhood obstructive sleep apnea syndromeIntermittent hypoxia and hypercapnia induce pulmonary artery atherosclerosis and ventricular dysfunction in low density lipoprotein receptor deficient mice.Inhibition of leukotriene B4 receptor 1 attenuates lipopolysaccharide-induced cardiac dysfunction: role of AMPK-regulated mitochondrial function.Update in sleep medicine 2011.Novel pharmacological approaches for treatment of obstructive sleep apnea in children.Molecular biology of atherosclerosis.Regulation of cytotoxic T-Lymphocyte trafficking to tumors by chemoattractants: implications for immunotherapy.Chronic intermittent hypoxia exposure-induced atherosclerosis: a brief review.Intermittent hypoxia-induced NF-κB and HO-1 regulation in human endothelial EA.hy926 cells.Circulating exosomes in obstructive sleep apnea as phenotypic biomarkers and mechanistic messengers of end-organ morbidity.Downregulation of uncoupling protein-1 mRNA expression and hypoadiponectinemia in a mouse model of sleep apnea.Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+ T Cell Migration into Tumors.Aorta macrophage inflammatory and epigenetic changes in a murine model of obstructive sleep apnea: Potential role of CD36.Potential inflammatory markers in obstructive sleep apnea-hypopnea syndrome.Intermittent hypoxia induces murine macrophage foam cell formation by IKK-β-dependent NF-κB pathway activation.Values of mean platelet volume in patients with chronic tonsillitis and adenoid hypertrophy.Intermittent Hypoxia and Hypercapnia Accelerate Atherosclerosis, Partially via Trimethylamine-Oxide.BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.Late gestational intermittent hypoxia induces metabolic and epigenetic changes in male adult offspring mice.Intermittent hypoxia induces NF-κB-dependent endothelial activation via adipocyte-derived mediators.Endothelin-1 mediates intermittent hypoxia-induced inflammatory vascular remodeling through HIF-1 activation.Effects and relationship of intermittent hypoxia on serum lipid levels, hepatic low-density lipoprotein receptor-related protein 1, and hypoxia-inducible factor 1α.The yin and yang of leukotriene B4 mediated inflammation in cancer.Effect of Combined Use of Astragaloside IV (AsIV) and Atorvastatin (AV) on Expression of PPAR-γ and Inflammation-Associated Cytokines in Atherosclerosis RatsBLTR1 in Monocytes Emerges as a Therapeutic Target For Vascular Inflammation With a Subsequent Intimal Hyperplasia in a Murine Wire-Injured Femoral Artery
P2860
Q26849304-F9934DD9-9877-4155-A08A-DDCECFD30D87Q28308192-2F2D13CD-0B6D-4FC6-800F-56D34A26AE0DQ28393077-305EBDA8-E4F8-4419-8E98-D69BF4470DEAQ34079885-D702BC76-A16A-4733-AAC4-681F8352C60EQ34359022-EE32864C-2BA7-42F9-AB85-01FF547C4E93Q36145246-A41D792D-F4EC-41A1-A070-D760FDADC9D1Q36355647-C26780BE-757B-433B-A545-C64FB11B3CEAQ36752050-FA67F3A9-8FF7-4ED4-9651-2B7B89DD93A8Q36911098-46D48ACB-9CFC-4AC0-B5D7-149CB46BF87CQ37081742-40896C61-0D9B-4E8F-B392-BF42E24E85BDQ37186987-1F61C081-B066-4D14-87EF-8FABAAFAB02BQ37274068-ED6E8D51-5F3A-4330-AB70-E0CF87D8CFB8Q37301940-92DA2D2E-02A9-45F8-AAD0-9CDAB7F263C4Q37441135-D825E203-7327-4D40-AC0B-1110AD1981C7Q37698696-52070486-74D0-40E6-8271-0E8A1BB36C36Q38019489-70A3F333-783E-4E8E-90E1-6F87C4214EF3Q38057797-ECA4464B-5746-4472-94FB-5B5F7C2AC921Q38125279-5A7D01B9-25DF-4601-8167-FB9BFA343626Q38284345-E5A2F4D1-7864-45F4-BF34-46B89711F261Q38593059-99E677E4-3913-479D-BCEC-30C8AF4BEFACQ39226510-90E4367D-4BBD-483D-A13A-D4F8C5A3DADBQ39413926-5C7F8A0C-6D61-4787-99B3-9AF25B052D4EQ40157811-FCE6B4DA-E920-4407-8D50-ED3D4993AD6DQ41483538-A0239E6A-C3B3-4783-A84F-DF5E75430D85Q41832970-963E64D3-10C2-489A-B570-06C4203F707FQ42317573-32B6B4A9-7500-4165-B7BA-F64F1415066BQ42356964-3093AC9A-325D-4B55-8D69-CE8E64ACE990Q42933260-5C718935-F6E2-445B-80FB-0AE7CE1F5D24Q46227294-9A20534B-2B0F-402C-BDA9-D5A103CE78B5Q47355559-5D42F312-9990-4A45-9E9D-B0A16DED6312Q47774432-25643DDF-D1AD-4DD4-BA48-89163340AA9BQ47901743-FE5ACB8D-F454-4990-83CB-5793C3B3FFA8Q47908376-AEE8D0DE-E264-4B18-A2F8-72EF76B2D364Q47964122-6F1E3E1A-0E91-4FB4-89AD-FD22DF767E18Q49573862-56C1C88A-D937-42ED-A3DC-ED2F12482CA6Q57159691-C44D1D78-F47C-47DB-A3A2-F58F2A5ABADDQ58698396-16C1E7B5-8A37-45B5-95DD-ECE20FF74DE8
P2860
Leukotriene B4 receptor-1 mediates intermittent hypoxia-induced atherogenesis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Leukotriene B4 receptor-1 mediates intermittent hypoxia-induced atherogenesis.
@ast
Leukotriene B4 receptor-1 mediates intermittent hypoxia-induced atherogenesis.
@en
type
label
Leukotriene B4 receptor-1 mediates intermittent hypoxia-induced atherogenesis.
@ast
Leukotriene B4 receptor-1 mediates intermittent hypoxia-induced atherogenesis.
@en
prefLabel
Leukotriene B4 receptor-1 mediates intermittent hypoxia-induced atherogenesis.
@ast
Leukotriene B4 receptor-1 mediates intermittent hypoxia-induced atherogenesis.
@en
P2093
P2860
P1476
Leukotriene B4 receptor-1 mediates intermittent hypoxia-induced atherogenesis.
@en
P2093
Bodduluri Haribabu
Jinkwan Kim
Richard C Li
Steven P Mathis
P2860
P304
P356
10.1164/RCCM.201012-2039OC
P407
P50
P577
2011-04-14T00:00:00Z